The tariff classification of Zolpidem (CAS-82626-48-0) in dosage form, from India
Issued December 5, 2008 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9130
Headings: 3004
Product description
The subject product, Zolpidem, is a medicinal preparation in tablet form containing Zolpidem, a nonbenzodiazepine hypnotic, as the active ingredient. It is used in the treatment for short term insomnia.
CBP rationale
The applicable subheading for the Zolpidem in dosage form will be 3004.90.9130, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives.
Full text
N045911 December 5, 2008 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9130 Mr. Colm Moynihan NorthStar Healthcare Ltd. 3300 Cork Airport Business Park Kinsale Road, Cork Ireland RE: The tariff classification of Zolpidem (CAS-82626-48-0) in dosage form, from India Dear Mr. Moynihan: In your letter dated December 1, 2008, you requested a tariff classification ruling. The subject product, Zolpidem, is a medicinal preparation in tablet form containing Zolpidem, a nonbenzodiazepine hypnotic, as the active ingredient. It is used in the treatment for short term insomnia. The applicable subheading for the Zolpidem in dosage form will be 3004.90.9130, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the central nervous system: Anticonvulsants, hypnotics and sedatives.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the requirements of the Controlled Substances Act, which are enforced by the U.S. Drug Enforcement Administration (DEA), Office of Diversion Control. You may contact them at 2401 Jefferson Davis Highway, Alexandria, VA 22301, telephone (800) 882-9539. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Dexmedetomidine Hydrochloride Injection in dosage form, from Finland
The tariff classification of Divalproex Sodium ER imported in dosage form, from the Netherlands. Correction to Ruling Number N270865.
The tariff classification of Divalproex Sodium ER imported in dosage form, from India
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
The tariff classification of Zonisamide Capsules, imported in dosage form, from India
The tariff classification of Levetiracetam Extended Release Tablets (CAS-102767-28-2) imported in dosage form, from India
The tariff classification of Levetiracetam Tablets (CAS-102767-28-2) imported in dosage form, from India
The tariff classification of Divalproex Sodium (CAS-76584-70-8), imported in dosage form, from India
The tariff classification of Gabapentin Tablets (CAS-60142-96-3), imported in dosage form, from India
The tariff classification of Lamotrigine Chewable Dispersible Tablets (CAS-84057-84-1), from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →